Dolby Laboratories (DLB) Stock Forecast, Price Target & Predictions
DLB Stock Forecast
Dolby Laboratories stock forecast is as follows: an average price target of $90.00 (represents a 12.15% upside from DLB’s last price of $80.25) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
DLB Price Target
The average price target for Dolby Laboratories (DLB) is $90.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $90.00 to $90.00. This represents a potential 12.15% upside from DLB's last price of $80.25.
DLB Analyst Ratings
According to 2 Wall Street analysts, Dolby Laboratories's rating consensus is 'Buy'. The analyst rating breakdown for DLB stock is 0 'Strong Buy' (0.00%), 1 'Buy' (50.00%), 1 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Dolby Laboratories Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Feb 03, 2023 | - | Rosenblatt Securities | $90.00 | $82.67 | 8.87% | 12.15% |
The latest Dolby Laboratories stock forecast, released on Feb 03, 2023 by Rosenblatt Securities company, set a price target of $90.00, which represents a 8.87% increase from the stock price at the time of the forecast ($82.67), and a 12.15% increase from DLB last price ($80.25).
Dolby Laboratories Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $80.25 | $80.25 | $80.25 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Dolby Laboratories stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Dolby Laboratories's last price of $80.25. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jun 07, 2024 | Rosenblatt Securities | Buy | Buy | Hold |
| Apr 26, 2022 | Zacks Investment Research | - | Hold | Upgrade |
Dolby Laboratories's last stock rating was published by Rosenblatt Securities on Jun 07, 2024. The company gave DLB a "Buy" rating, the same as its previous rate.
Dolby Laboratories Financial Forecast
Dolby Laboratories Revenue Forecast
| Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $290.56M | $298.37M | $375.89M | $334.92M | $278.20M | $289.58M | $334.37M | $351.63M | $285.02M | $286.80M | $319.56M | $389.87M | $271.19M | $246.91M | $351.81M | $291.88M | $298.83M | $302.16M | $338.26M | $301.36M | $267.47M | $233.00M |
| Avg Forecast | $322.34M | $302.77M | $371.34M | $337.94M | $307.94M | $292.85M | $359.43M | $312.16M | $290.20M | $301.66M | $349.85M | $306.56M | $305.23M | $293.92M | $332.51M | $359.38M | $299.95M | $278.79M | $294.29M | $345.33M | $244.43M | $232.61M | $361.35M | $285.81M | $297.55M | $305.29M | $337.45M | $290.62M | $256.58M | $202.61M |
| High Forecast | $335.70M | $315.32M | $385.61M | $352.71M | $307.94M | $293.20M | $359.43M | $321.41M | $295.30M | $314.16M | $364.35M | $319.27M | $305.23M | $293.92M | $332.51M | $359.38M | $299.95M | $278.79M | $294.29M | $345.33M | $244.43M | $232.61M | $361.35M | $285.81M | $297.55M | $305.29M | $337.45M | $348.74M | $307.90M | $243.13M |
| Low Forecast | $312.58M | $293.60M | $357.42M | $328.66M | $307.93M | $292.49M | $359.43M | $303.12M | $280.15M | $292.52M | $339.26M | $297.28M | $305.23M | $293.92M | $332.51M | $359.38M | $299.95M | $278.79M | $294.29M | $345.33M | $244.43M | $232.61M | $361.35M | $285.81M | $297.55M | $305.29M | $337.45M | $232.49M | $205.27M | $162.09M |
| # Analysts | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 3 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 8 | 5 | 4 | 9 | 6 | 4 | 11 | 15 | 11 |
| Surprise % | - | - | - | - | - | - | - | - | 1.00% | 0.99% | 1.07% | 1.09% | 0.91% | 0.99% | 1.01% | 0.98% | 0.95% | 1.03% | 1.09% | 1.13% | 1.11% | 1.06% | 0.97% | 1.02% | 1.00% | 0.99% | 1.00% | 1.04% | 1.04% | 1.15% |
Dolby Laboratories's average Quarter revenue forecast for Dec 23 based on 3 analysts is $312.16M, with a low forecast of $303.12M, and a high forecast of $321.41M. DLB's average Quarter revenue forecast represents a 7.43% increase compared to the company's last Quarter revenue of $290.56M (Sep 23).
Dolby Laboratories EBITDA Forecast
| Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 3 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 8 | 5 | 4 | 9 | 6 | 4 | 11 | 15 | 11 |
| EBITDA | - | - | - | - | - | - | - | - | $81.95M | $15.94M | $109.29M | $122.18M | $35.69M | $77.73M | $75.06M | $118.85M | $42.51M | $82.67M | $111.51M | $185.37M | $34.50M | $65.23M | $130.45M | $75.44M | $84.92M | $94.08M | $130.82M | $110.15M | $88.48M | $52.16M |
| Avg Forecast | $93.76M | $88.07M | $108.02M | $98.30M | $89.57M | $85.18M | $74.48M | $90.80M | $84.41M | $87.75M | $67.71M | $137.02M | $88.78M | $85.50M | $61.55M | $104.54M | $87.25M | $81.09M | $71.01M | $100.45M | $71.10M | $67.66M | $136.59M | $83.14M | $86.55M | $88.80M | $85.44M | $105.04M | $84.59M | $44.22M |
| High Forecast | $97.65M | $91.72M | $112.17M | $102.60M | $89.57M | $85.29M | $89.38M | $93.49M | $85.90M | $91.38M | $81.25M | $164.42M | $88.78M | $85.50M | $73.86M | $104.54M | $87.25M | $81.09M | $85.21M | $100.45M | $71.10M | $67.66M | $163.91M | $83.14M | $86.55M | $88.80M | $102.52M | $126.05M | $101.50M | $53.07M |
| Low Forecast | $90.92M | $85.40M | $103.97M | $95.60M | $89.57M | $85.08M | $59.58M | $88.17M | $81.49M | $85.09M | $54.17M | $109.61M | $88.78M | $85.50M | $49.24M | $104.54M | $87.25M | $81.09M | $56.80M | $100.45M | $71.10M | $67.66M | $109.27M | $83.14M | $86.55M | $88.80M | $68.35M | $84.03M | $67.67M | $35.38M |
| Surprise % | - | - | - | - | - | - | - | - | 0.97% | 0.18% | 1.61% | 0.89% | 0.40% | 0.91% | 1.22% | 1.14% | 0.49% | 1.02% | 1.57% | 1.85% | 0.49% | 0.96% | 0.96% | 0.91% | 0.98% | 1.06% | 1.53% | 1.05% | 1.05% | 1.18% |
3 analysts predict DLB's average Quarter EBITDA for Dec 23 to be $90.80M, with a high of $93.49M and a low of $88.17M. This is 10.79% upper than Dolby Laboratories's previous annual EBITDA (Sep 23) of $81.95M.
Dolby Laboratories Net Income Forecast
| Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 3 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 8 | 5 | 4 | 9 | 6 | 4 | 11 | 15 | 11 |
| Net Income | - | - | - | - | - | - | - | - | $9.19M | $31.11M | $95.70M | $79.38M | $27.76M | $39.60M | $36.72M | $80.01M | $44.19M | $54.62M | $76.22M | $135.20M | $26.83M | $67.28M | $88.50M | $48.75M | $43.92M | $39.57M | $73.44M | $70.63M | $50.59M | $23.93M |
| Avg Forecast | $60.56M | $46.89M | $84.98M | $77.17M | $43.47M | $29.79M | $39.01M | $51.86M | $21.63M | $27.14M | $35.47M | $92.17M | $39.56M | $34.47M | $32.24M | $77.66M | $34.43M | $26.95M | $48.92M | $77.75M | $14.46M | $8.01M | $92.56M | $29.69M | $47.23M | $47.67M | $48.02M | $63.16M | $48.44M | $20.34M |
| High Forecast | $63.82M | $49.41M | $89.41M | $83.54M | $46.66M | $31.40M | $46.82M | $52.44M | $22.45M | $28.60M | $42.56M | $110.60M | $39.56M | $34.47M | $38.69M | $77.66M | $34.43M | $26.95M | $58.70M | $77.75M | $14.46M | $8.01M | $111.07M | $29.69M | $47.23M | $47.67M | $57.62M | $75.80M | $58.12M | $24.41M |
| Low Forecast | $58.18M | $45.04M | $82.02M | $73.63M | $40.91M | $28.62M | $31.21M | $50.69M | $20.41M | $26.07M | $28.37M | $73.73M | $39.56M | $34.47M | $25.79M | $77.66M | $34.43M | $26.95M | $39.13M | $77.75M | $14.46M | $8.01M | $74.04M | $29.69M | $47.23M | $47.67M | $38.41M | $50.53M | $38.75M | $16.27M |
| Surprise % | - | - | - | - | - | - | - | - | 0.42% | 1.15% | 2.70% | 0.86% | 0.70% | 1.15% | 1.14% | 1.03% | 1.28% | 2.03% | 1.56% | 1.74% | 1.86% | 8.40% | 0.96% | 1.64% | 0.93% | 0.83% | 1.53% | 1.12% | 1.04% | 1.18% |
Dolby Laboratories's average Quarter net income forecast for Dec 23 is $51.86M, with a range of $50.69M to $52.44M. DLB's average Quarter net income forecast represents a 464.50% increase compared to the company's last Quarter net income of $9.19M (Sep 23).
Dolby Laboratories SG&A Forecast
| Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 3 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 8 | 5 | 4 | 9 | 6 | 4 | 11 | 15 | 11 |
| SG&A | - | - | - | - | - | - | - | - | $157.48M | $155.55M | $157.63M | $142.18M | $147.27M | $144.23M | $182.92M | $159.61M | $152.66M | $136.83M | $137.44M | $129.90M | $136.98M | $121.78M | $149.28M | $147.65M | $135.16M | $137.57M | $140.11M | $124.77M | $118.87M | $114.49M |
| Avg Forecast | $149.06M | $140.01M | $171.72M | $156.28M | $142.40M | $135.42M | $194.34M | $144.35M | $134.20M | $139.50M | $176.68M | $183.86M | $141.15M | $135.92M | $160.62M | $166.19M | $138.71M | $128.92M | $88.21M | $159.69M | $113.03M | $107.57M | $156.13M | $132.17M | $137.60M | $141.18M | $91.61M | $120.90M | $113.81M | $97.31M |
| High Forecast | $155.24M | $145.81M | $178.32M | $163.10M | $142.40M | $135.59M | $233.21M | $148.63M | $136.56M | $145.28M | $212.01M | $220.63M | $141.15M | $135.92M | $192.74M | $166.19M | $138.71M | $128.92M | $105.85M | $159.69M | $113.03M | $107.57M | $187.36M | $132.17M | $137.60M | $141.18M | $109.93M | $145.08M | $136.58M | $116.78M |
| Low Forecast | $144.55M | $135.77M | $165.28M | $151.98M | $142.40M | $135.26M | $155.48M | $140.17M | $129.55M | $135.27M | $141.34M | $147.09M | $141.15M | $135.92M | $128.49M | $166.19M | $138.71M | $128.92M | $70.57M | $159.69M | $113.03M | $107.57M | $124.91M | $132.17M | $137.60M | $141.18M | $73.29M | $96.72M | $91.05M | $77.85M |
| Surprise % | - | - | - | - | - | - | - | - | 1.17% | 1.12% | 0.89% | 0.77% | 1.04% | 1.06% | 1.14% | 0.96% | 1.10% | 1.06% | 1.56% | 0.81% | 1.21% | 1.13% | 0.96% | 1.12% | 0.98% | 0.97% | 1.53% | 1.03% | 1.04% | 1.18% |
Dolby Laboratories's average Quarter SG&A projection for Dec 23 is $144.35M, based on 3 Wall Street analysts, with a range of $140.17M to $148.63M. The forecast indicates a -8.34% fall compared to DLB last annual SG&A of $157.48M (Sep 23).
Dolby Laboratories EPS Forecast
| Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 3 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 8 | 5 | 4 | 9 | 6 | 4 | 11 | 15 | 11 |
| EPS | - | - | - | - | - | - | - | - | $0.10 | $0.33 | $1.00 | $0.83 | $0.29 | $0.40 | $0.36 | $0.79 | $0.44 | $0.54 | $0.75 | $1.34 | $0.27 | $0.67 | $0.88 | $0.49 | $0.44 | $0.39 | $0.72 | $0.68 | $0.50 | $0.24 |
| Avg Forecast | $0.62 | $0.48 | $0.87 | $0.79 | $0.45 | $0.30 | $1.01 | $0.53 | $0.22 | $0.28 | $0.68 | $0.48 | $0.41 | $0.35 | $0.52 | $0.80 | $0.35 | $0.28 | $0.46 | $0.80 | $0.15 | $0.08 | $0.90 | $0.30 | $0.48 | $0.49 | $0.52 | $0.62 | $0.45 | $0.17 |
| High Forecast | $0.65 | $0.51 | $0.92 | $0.86 | $0.48 | $0.32 | $1.01 | $0.54 | $0.23 | $0.29 | $0.71 | $0.51 | $0.41 | $0.35 | $0.52 | $0.80 | $0.35 | $0.28 | $0.46 | $0.80 | $0.15 | $0.08 | $0.90 | $0.30 | $0.48 | $0.49 | $0.52 | $0.74 | $0.54 | $0.20 |
| Low Forecast | $0.60 | $0.46 | $0.84 | $0.75 | $0.42 | $0.29 | $1.01 | $0.52 | $0.21 | $0.27 | $0.65 | $0.47 | $0.41 | $0.35 | $0.52 | $0.80 | $0.35 | $0.28 | $0.46 | $0.80 | $0.15 | $0.08 | $0.90 | $0.30 | $0.48 | $0.49 | $0.52 | $0.50 | $0.36 | $0.14 |
| Surprise % | - | - | - | - | - | - | - | - | 0.45% | 1.19% | 1.48% | 1.71% | 0.72% | 1.13% | 0.69% | 0.99% | 1.25% | 1.96% | 1.64% | 1.68% | 1.82% | 8.17% | 0.98% | 1.61% | 0.91% | 0.80% | 1.39% | 1.10% | 1.11% | 1.41% |
According to 3 Wall Street analysts, Dolby Laboratories's projected average Quarter EPS for Dec 23 is $0.53, with a low estimate of $0.52 and a high estimate of $0.54. This represents a 430.88% increase compared to DLB previous annual EPS of $0.10 (Sep 23).